earnings
TE
NASDAQ · TELA
TELA Bio, Inc.
Healthcare · Medical - Devices
$0.97
Up+$0.06 (+7.17%)
Updated Sep 14, 2026, 1:21 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 45.56M
- P/E ratio
- -1.32
- Dividend yield
- 0.00%
- 52-week range
- $0.50 – $1.27
- Volume
- 254.21K
- Avg. volume
- 183.24K
Price performance
TELA price history
1M range · 19 trading sessions · Daily adjusted prices
TELA closed at $0.97 after 19 trading sessions, up 49.23% for the selected period.
- Last close
- $0.97
- Period change
- +49.23%
- Period low
- $0.64
- Period high
- $0.97
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.8879 | $0.9873 | $0.85 | $0.97 | 254.21K |
| Sep 10, 2026 | $0.9054 | $0.9054 | $0.8511 | $0.9051 | 130.28K |
| Sep 9, 2026 | $0.83 | $0.94 | $0.83 | $0.9113 | 298.29K |
| Sep 8, 2026 | $0.8499 | $0.87 | $0.8114 | $0.8301 | 121.41K |
| Sep 4, 2026 | $0.794 | $0.8433 | $0.7899 | $0.8215 | 115.65K |
| Sep 3, 2026 | $0.75 | $0.92 | $0.75 | $0.781 | 522.63K |
| Sep 2, 2026 | $0.771 | $0.83 | $0.739 | $0.7524 | 129.08K |
| Sep 1, 2026 | $0.721 | $0.839 | $0.721 | $0.7913 | 300.52K |
| Aug 31, 2026 | $0.68 | $0.85 | $0.68 | $0.738 | 533.97K |
| Aug 28, 2026 | $0.668 | $0.70 | $0.6501 | $0.70 | 124.08K |
| Aug 27, 2026 | $0.6701 | $0.7002 | $0.639 | $0.65 | 134.38K |
| Aug 26, 2026 | $0.679 | $0.6996 | $0.6539 | $0.6911 | 61.97K |
| Aug 25, 2026 | $0.65 | $0.70 | $0.65 | $0.70 | 131.26K |
| Aug 24, 2026 | $0.6561 | $0.6561 | $0.6229 | $0.654 | 2.07M |
| Aug 21, 2026 | $0.6799 | $0.6801 | $0.6251 | $0.6463 | 59.8K |
| Aug 20, 2026 | $0.659 | $0.6799 | $0.6303 | $0.6393 | 95.96K |
| Aug 19, 2026 | $0.66 | $0.6699 | $0.6035 | $0.647 | 119.04K |
| Aug 18, 2026 | $0.65 | $0.689 | $0.616 | $0.643 | 297.02K |
| Aug 17, 2026 | $0.64 | $0.6913 | $0.622 | $0.65 | 241.52K |
Latest TELA news
The latest Smart Investors Daily articles mentioning TELA.
Stock researchResearch & News · SID Coverage
Loading stock research…

